Key statistics
As of last trade Rezolute Inc (RZLT:NAQ) traded at 4.99, -18.20% below its 52-week high of 6.10, set on Jun 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.21 |
---|---|
High | 5.44 |
Low | 4.82 |
Bid | 4.98 |
Offer | 4.99 |
Previous close | 4.82 |
Average volume | 472.40k |
---|---|
Shares outstanding | 51.38m |
Free float | 45.01m |
P/E (TTM) | -- |
Market cap | 247.66m USD |
EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:29 BST.
More ▼
- Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
- FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
- Rezolute to Participate in Upcoming Investor Conferences
- Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
- Rezolute to Participate in the BTIG Virtual Biotechnology Conference
- Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
- Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
- Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
- Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Rezolute to Participate in the Jefferies Global Healthcare Conference
More ▼